Skip to main content
👥communitySource: estrato.cc

Oncoclinicas (ONCO3) vê prejuízo saltar 234%, para R$ 475 milhões; emp

A Oncoclinicas ONCO3 , que passa por momento delicado na Bolsa, viu os seus números pioraram no segundo trimestre de 2025, com prejuízo de R$ 475,7.

1 min read26 words

A Oncoclinicas (ONCO3), que passa por momento delicado na Bolsa, viu os seus números pioraram no segundo trimestre de 2025, com prejuízo de R$ 475,7

Source Attribution
OpenDocs keeps source fields explicit. Unknown values are labeled instead of invented.

Source domain

estrato.cc

Author

Unknown

Publisher

estrato.cc

License / usage

Unknown. Review the original source terms before republishing beyond public-safe excerpts.

Score
Version docs-phase3-2026-05-20
78

Overall quality score, confidence 81%

Source credibility90
Freshness100
Completeness69
Extraction quality45
Attribution confidence90
Readability
difficult | grade 14.1 | format 47

1 sentences, 0 headings, 0 list items.

Keep source attribution visible in the rendered document.

Search Appearance
plain_blue_link, generic_rich_result
OpenDocs keeps inspected URLs, canonical URLs, snippets, and rich-result signals explicit; Search Console metrics are not treated as visits.
Social Card
Oncoclinicas (ONCO3) vê prejuízo saltar 234%, para R$ 475 milhões; emp
A Oncoclinicas ONCO3 , que passa por momento delicado na Bolsa, viu os seus números pioraram no segundo trimestre de 2025, com prejuízo de R$ 475,7.
Duplicate State
No duplicate is asserted on this page without a matching canonical URL or content hash cluster.
Trace
docs-score-99e196d4e54b7392bcacdb50
Export
Use public export endpoints for Markdown/JSON. Protected publishing still requires PLATPHORM_API_KEY.